ResMed Total Liabilities 2010-2025 | RMD
ResMed total liabilities from 2010 to 2025. Total liabilities can be defined as the total value of all possible claims against the corporation.
- ResMed total liabilities for the quarter ending March 31, 2025 were $2.021B, a 7.5% decline year-over-year.
- ResMed total liabilities for 2024 were $2.008B, a 23.4% decline from 2023.
- ResMed total liabilities for 2023 were $2.622B, a 51.1% increase from 2022.
- ResMed total liabilities for 2022 were $1.735B, a 5.83% decline from 2021.
| ResMed Annual Total Liabilities (Millions of US $) |
|
|---|---|
| 2024 | $2,008 |
| 2023 | $2,622 |
| 2022 | $1,735 |
| 2021 | $1,842 |
| 2020 | $2,090 |
| 2019 | $2,035 |
| 2018 | $1,005 |
| 2017 | $1,508 |
| 2016 | $1,562 |
| 2015 | $594 |
| 2014 | $603 |
| 2013 | $600 |
| 2012 | $530 |
| 2011 | $338 |
| 2010 | $339 |
| 2009 | $393 |
| ResMed Quarterly Total Liabilities (Millions of US $) |
|
|---|---|
| 2025-03-31 | $2,021 |
| 2024-12-31 | $1,888 |
| 2024-09-30 | $2,027 |
| 2024-06-30 | $2,008 |
| 2024-03-31 | $2,185 |
| 2023-12-31 | $2,423 |
| 2023-09-30 | $2,490 |
| 2023-06-30 | $2,622 |
| 2023-03-31 | $2,781 |
| 2022-12-31 | $2,938 |
| 2022-09-30 | $1,745 |
| 2022-06-30 | $1,735 |
| 2022-03-31 | $1,626 |
| 2021-12-31 | $1,589 |
| 2021-09-30 | $1,703 |
| 2021-06-30 | $1,842 |
| 2021-03-31 | $1,876 |
| 2020-12-31 | $1,708 |
| 2020-09-30 | $1,942 |
| 2020-06-30 | $2,090 |
| 2020-03-31 | $2,254 |
| 2019-12-31 | $2,096 |
| 2019-09-30 | $2,037 |
| 2019-06-30 | $2,035 |
| 2019-03-31 | $2,077 |
| 2018-12-31 | $1,904 |
| 2018-09-30 | $1,167 |
| 2018-06-30 | $1,005 |
| 2018-03-31 | $1,467 |
| 2017-12-31 | $1,544 |
| 2017-09-30 | $1,440 |
| 2017-06-30 | $1,508 |
| 2017-03-31 | $1,568 |
| 2016-12-31 | $1,612 |
| 2016-09-30 | $1,550 |
| 2016-06-30 | $1,562 |
| 2016-03-31 | $771 |
| 2015-12-31 | $715 |
| 2015-09-30 | $794 |
| 2015-06-30 | $594 |
| 2015-03-31 | $742 |
| 2014-12-31 | $738 |
| 2014-09-30 | $656 |
| 2014-06-30 | $603 |
| 2014-03-31 | $674 |
| 2013-12-31 | $707 |
| 2013-09-30 | $642 |
| 2013-06-30 | $600 |
| 2013-03-31 | $607 |
| 2012-12-31 | $579 |
| 2012-09-30 | $546 |
| 2012-06-30 | $530 |
| 2012-03-31 | $520 |
| 2011-12-31 | $480 |
| 2011-09-30 | $386 |
| 2011-06-30 | $338 |
| 2011-03-31 | $299 |
| 2010-12-31 | $273 |
| 2010-09-30 | $315 |
| 2010-06-30 | $339 |
| 2010-03-31 | $381 |
| 2009-12-31 | $364 |
| 2009-09-30 | $417 |
| 2009-06-30 | $393 |
| 2009-03-31 | $353 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $37.413B | $4.685B |
| ResMed, Inc. holds a major position as designer, manufacturer, as well as a distributor in the worldwide market for generators, masks, and related accessories for the treatment of sleep-disordered breathing (SDB) and other respiratory disorders. SDB includes obstructive sleep apnea (OSA) and other respiratory disorders that occur during sleep. The company currently has two operating segments, which are the Sleep and Respiratory Care segment and the Software-as-a-Service segment. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $233.799B | 28.11 |
| Boston Scientific (BSX) | United States | $157.605B | 39.46 |
| Stryker (SYK) | United States | $150.214B | 31.41 |
| EssilorLuxottica (ESLOY) | France | $126.765B | 0.00 |
| Medtronic (MDT) | Ireland | $110.324B | 15.64 |
| Lonza Group Ag (LZAGY) | Switzerland | $50.804B | 0.00 |
| Haleon (HLN) | United Kingdom | $46.650B | 26.61 |
| GE HealthCare Technologies (GEHC) | United States | $34.057B | 16.17 |
| Agilent Technologies (A) | United States | $33.852B | 22.07 |
| Terumo (TRUMY) | Japan | $27.835B | 36.15 |
| Koninklijke Philips (PHG) | Netherlands | $23.245B | 16.31 |
| Insulet (PODD) | United States | $22.033B | 86.49 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.095B | 11.62 |
| Baxter (BAX) | United States | $15.595B | 11.64 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $13.236B | 0.00 |
| Demant (WILYY) | Denmark | $9.110B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $8.561B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.639B | 23.10 |
| Lantheus Holdings (LNTH) | United States | $5.638B | 14.22 |
| Prestige Consumer Healthcare (PBH) | United States | $3.998B | 17.86 |
| Perrigo (PRGO) | Ireland | $3.649B | 9.25 |
| Haemonetics (HAE) | United States | $3.545B | 16.15 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Envista Holdings (NVST) | United States | $3.334B | 27.70 |
| ICU Medical (ICUI) | United States | $3.244B | 23.92 |
| GN Store Nord (GNNDY) | Denmark | $2.307B | 19.11 |
| QuidelOrtho (QDEL) | United States | $1.952B | 13.43 |
| LeMaitre Vascular (LMAT) | United States | $1.866B | 41.70 |
| AtriCure (ATRC) | United States | $1.598B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.289B | 13.08 |
| Acuren (TIC) | United States | $1.271B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.111B | 25.00 |
| Phibro Animal Health (PAHC) | United States | $1.040B | 13.30 |
| Neogen (NEOG) | United States | $1.027B | 13.14 |
| BioLife Solutions (BLFS) | United States | $1.021B | 0.00 |
| Kestra Medical Technologies (KMTS) | United States | $0.907B | 0.00 |
| InMode (INMD) | Israel | $0.897B | 9.04 |
| Owens & Minor (OMI) | United States | $0.685B | 5.69 |
| CeriBell (CBLL) | United States | $0.683B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.629B | 0.00 |
| Evolus (EOLS) | United States | $0.589B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.531B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.509B | 0.00 |
| Valneva SE (VALN) | France | $0.494B | 0.00 |
| Surmodics (SRDX) | United States | $0.412B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.403B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.354B | 13.00 |
| Quanterix (QTRX) | United States | $0.332B | 0.00 |
| SNDL (SNDL) | Canada | $0.323B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.301B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.274B | 23.07 |
| Cerus (CERS) | United States | $0.271B | 0.00 |
| ZimVie (ZIMV) | United States | $0.258B | 11.72 |
| Sanuwave Health (SNWV) | United States | $0.256B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.253B | 0.00 |
| Brainsway (BWAY) | Israel | $0.250B | 66.10 |
| Cresco Labs (CRLBF) | United States | $0.246B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.233B | 69.17 |
| Biote (BTMD) | United States | $0.230B | 6.46 |
| OraSure Technologies (OSUR) | United States | $0.225B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.224B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.201B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.188B | 15.29 |
| Omeros (OMER) | United States | $0.188B | 0.00 |
| High Tide (HITI) | Canada | $0.184B | 0.00 |
| Organigram Global (OGI) | Canada | $0.181B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.177B | 0.00 |
| Exagen (XGN) | United States | $0.149B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.144B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.120B | 0.00 |
| Jin Medical (ZJYL) | China | $0.102B | 0.00 |
| Fonar (FONR) | United States | $0.092B | 11.90 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.088B | 0.00 |
| Veru (VERU) | United States | $0.085B | 0.00 |
| Apyx Medical (APYX) | United States | $0.082B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.078B | 0.00 |
| Zynex (ZYXI) | United States | $0.077B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.077B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.077B | 0.00 |
| MacroGenics (MGNX) | United States | $0.075B | 0.00 |
| InterCure (INCR) | Israel | $0.068B | 0.00 |
| Agape ATP (ATPC) | $0.066B | 0.00 | |
| ImmuCell (ICCC) | United States | $0.061B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.057B | 0.00 |
| Nephros (NEPH) | United States | $0.041B | 55.14 |
| United-Guardian (UG) | United States | $0.037B | 12.94 |
| Modular Medical (MODD) | United States | $0.037B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.027B | 0.00 |
| Safety Shot (SHOT) | United States | $0.023B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.018B | 0.00 |
| INLIF (INLF) | $0.016B | 0.00 | |
| Meihua Medical Technologies (MHUA) | China | $0.014B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.014B | 0.00 |
| Flora Growth (FLGC) | United States | $0.014B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.012B | 0.00 |
| Senestech (SNES) | United States | $0.010B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.006B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.006B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |